228 related articles for article (PubMed ID: 7848920)
1. Protein kinase C isozymes in progressively transformed rat embryo fibroblasts.
Liao L; Ramsay K; Jaken S
Cell Growth Differ; 1994 Nov; 5(11):1185-94. PubMed ID: 7848920
[TBL] [Abstract][Full Text] [Related]
2. Increased protein kinase C delta in mammary tumor cells: relationship to transformtion and metastatic progression.
Kiley SC; Clark KJ; Duddy SK; Welch DR; Jaken S
Oncogene; 1999 Nov; 18(48):6748-57. PubMed ID: 10597283
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of protein kinase C epsilon is oncogenic in rat colonic epithelial cells.
Perletti GP; Folini M; Lin HC; Mischak H; Piccinini F; Tashjian AH
Oncogene; 1996 Feb; 12(4):847-54. PubMed ID: 8632907
[TBL] [Abstract][Full Text] [Related]
4. Induction of transformation progression in type 5 adenovirus-transformed rat embryo cells by a cloned protein kinase C beta 1 gene and reversal of progression by 5-azacytidine.
Su ZZ; Shen R; O'Brian CA; Fisher PB
Oncogene; 1994 Apr; 9(4):1123-32. PubMed ID: 7510863
[TBL] [Abstract][Full Text] [Related]
5. Effects of protein kinase C alpha overexpression on A7r5 smooth muscle cell proliferation and differentiation.
Wang S; Desai D; Wright G; Niles RM; Wright GL
Exp Cell Res; 1997 Oct; 236(1):117-26. PubMed ID: 9344591
[TBL] [Abstract][Full Text] [Related]
6. Changes in nuclear protein kinase C-delta holoenzyme, its catalytic fragments, and its activity in polyomavirus-transformed pyF111 rat fibroblasts while proliferating and following exposure to apoptogenic topoisomerase-II inhibitors.
Dal Pra I; Whitfield JF; Chiarini A; Armato U
Exp Cell Res; 1999 May; 249(1):147-60. PubMed ID: 10328962
[TBL] [Abstract][Full Text] [Related]
7. Effect of alpha-protein kinase C neutralizing antibodies and the pseudosubstrate peptide on phosphorylation, migration, and growth of REF52 cells.
Liao L; Jaken S
Cell Growth Differ; 1993 Apr; 4(4):309-16. PubMed ID: 8494793
[TBL] [Abstract][Full Text] [Related]
8. The catalytic domain of PKC-epsilon, in reciprocal PKC-delta and -epsilon chimeras, is responsible for conferring tumorgenicity to NIH3T3 cells, whereas both regulatory and catalytic domains of PKC-epsilon contribute to in vitro transformation.
Wang QJ; Acs P; Goodnight J; Blumberg PM; Mischak H; Mushinski JF
Oncogene; 1998 Jan; 16(1):53-60. PubMed ID: 9467942
[TBL] [Abstract][Full Text] [Related]
9. Regulation of expression and activity of four PKC isozymes in confluent and mechanically stimulated UMR-108 osteoblastic cells.
Geng WD; Boskovic G; Fultz ME; Li C; Niles RM; Ohno S; Wright GL
J Cell Physiol; 2001 Nov; 189(2):216-28. PubMed ID: 11598907
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C isozyme expression and down-modulation in growing, quiescent, and transformed renal proximal tubule epithelial cells.
Dong L; Stevens JL; Fabbro D; Jaken S
Cell Growth Differ; 1994 Aug; 5(8):881-90. PubMed ID: 7986753
[TBL] [Abstract][Full Text] [Related]
11. Transformation by a ras oncogene causes increased expression of protein kinase C-alpha and decreased expression of protein kinase C-epsilon.
Borner C; Guadagno SN; Hsieh LL; Hsiao WL; Weinstein IB
Cell Growth Differ; 1990 Dec; 1(12):653-60. PubMed ID: 2288879
[TBL] [Abstract][Full Text] [Related]
12. The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts.
Cacace AM; Guadagno SN; Krauss RS; Fabbro D; Weinstein IB
Oncogene; 1993 Aug; 8(8):2095-104. PubMed ID: 8336936
[TBL] [Abstract][Full Text] [Related]
13. Functional effects of overexpression of protein kinase C-alpha, -beta, -delta, -epsilon, and -eta in the mast cell line RBL-2H3.
Chang EY; Szallasi Z; Acs P; Raizada V; Wolfe PC; Fewtrell C; Blumberg PM; Rivera J
J Immunol; 1997 Sep; 159(6):2624-32. PubMed ID: 9300681
[TBL] [Abstract][Full Text] [Related]
14. Selective activation of protein kinase C isoforms by v-Src.
Zang Q; Frankel P; Foster DA
Cell Growth Differ; 1995 Nov; 6(11):1367-73. PubMed ID: 8562474
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C-epsilon associates with the Raf-1 kinase and induces the production of growth factors that stimulate Raf-1 activity.
Ueffing M; Lovrić J; Philipp A; Mischak H; Kolch W
Oncogene; 1997 Dec; 15(24):2921-7. PubMed ID: 9416835
[TBL] [Abstract][Full Text] [Related]
16. Selective ceramide binding to protein kinase C-alpha and -delta isoenzymes in renal mesangial cells.
Huwiler A; Fabbro D; Pfeilschifter J
Biochemistry; 1998 Oct; 37(41):14556-62. PubMed ID: 9772184
[TBL] [Abstract][Full Text] [Related]
17. Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells.
Li W; Michieli P; Alimandi M; Lorenzi MV; Wu Y; Wang LH; Heidaran MA; Pierce JH
Oncogene; 1996 Aug; 13(4):731-7. PubMed ID: 8761294
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C isoform expression and function in transformed and non-transformed pancreatic acinar cell lines.
Raffaniello RD; Nam J; Cho I; Lin J; Bao LY; Michl J; Raufman JP
Biochem Biophys Res Commun; 1998 May; 246(1):166-71. PubMed ID: 9600087
[TBL] [Abstract][Full Text] [Related]
19. Aflatoxin-transformed C3H/10T1/2 cells overexpress protein kinase C and have an altered response to phorbol ester treatments.
Dunn JA; Faletto MB; Kasper SJ; Gurtoo HL
Cancer Res; 1992 Feb; 52(4):990-6. PubMed ID: 1737362
[TBL] [Abstract][Full Text] [Related]
20. EGF-induced ERK phosphorylation independent of PKC isozymes in human corneal epithelial cells.
Xu KP; Dartt DA; Yu FS
Invest Ophthalmol Vis Sci; 2002 Dec; 43(12):3673-9. PubMed ID: 12454035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
